In fall, Horizon announced its plan to handle increased sickness over winter, determined to avoid a repeat of the winter of ...

Pfizer has won European Commission expanded approval of its Abrysvo vaccine for respiratory syncytial virus, or RSV, for use in all adults. The New York drugmaker on Tuesday said the extended ...

The European Commission (EC) has issued a decision amending the marketing authorization for Abrysvo, US pharma giant Pfizer’s ...

Pfizer Inc. (NYSE: PFE) announced today that the European Commission (EC) has issued a decision amending the marketing ...

The European Commission approved Pfizer's respiratory syncytial virus vaccine for the prevention of lower respiratory tract ...

The long-acting Respiratory Syncytial Virus (RSV) immunisation is now available free for eligible families until 30 September ...

The Royal Australian College of GPs (RACGP) has thrown its support behind Victoria's infant RSV vaccine program.Respiratory syncytial virus, or RSV ...

Largest childhood preventative health initiative in nearly 20 yearsBeyfortus rollout to ensure all babies are RSV protected this winterThe largest ...

The New York State Department of Agriculture and Markets on March 28 warned consumers about the risk of H5N1 avian flu from ...

The risk for new-onset or recurrent AF was not increased among older adult patients with preexisting conditions following RSV vaccination.

England’s RSV vaccination programme has achieved a 30% reduction in RSV-related hospital admissions among older adults.